NEW YORK, July 23 – GeneMachines has licensed two patents covering microarray fabrication technology from Incyte Genomics, the company said Monday.

The license will allow GeneMachines, based in San Carlos, Calif., to sell its microarray printing machines, the OmniGrid and OmniGrid Accent, with label licenses for research use. In a statement, the company made no mention of any changes to their microarraying products, which have been available to customers for several years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.